Tue, Jul 29, 2014, 11:36 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

TG Therapeutics, Inc. Message Board

  • slumdawg2011 slumdawg2011 Nov 1, 2013 2:34 PM Flag

    Roche anti-CD20 drug approved for CLL

    Breakthrough therapy, priority review. The trial showed that people who received Gazyva in combination with chlorambucil chemotherapy had significantly reduced risk of disease progression or death (HR=0.16; p

 
TGTX
7.94+0.03(+0.38%)Jul 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.